| Mohammad K. Khan, M.d., Llc | |
|
4949 Liberty Ln Suite 140 Allentown PA 18106-9014 | |
| (717) 319-1706 | |
| Not Available |
| Full Name | Mohammad K. Khan, M.d., Llc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 4949 Liberty Ln, Allentown, Pennsylvania |
| Authorized Official Name and Position | Mohammad Khalid Khan (OWNER) |
| Authorized Official Contact | 7173191706 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Mohammad K. Khan, M.d., Llc 6594 Rutherford Dr Macungie PA 18062-8049 Ph: (717) 319-1706 | Mohammad K. Khan, M.d., Llc 4949 Liberty Ln Suite 140 Allentown PA 18106-9014 Ph: (717) 319-1706 |
| NPI Number | 1184946428 |
|---|---|
| Provider Enumeration Date | 02/26/2010 |
| Last Update Date | 04/22/2011 |
| Medicare PECOS PAC ID | 2466576327 |
|---|---|
| Medicare Enrollment ID | O20100830000110 |
News Archive
Cell biologist Benjamin J. Perrin of the School of Science at Indiana University-Purdue University Indianapolis is advancing knowledge of age-related hearing loss with the goal of informing possible therapeutic cell-regeneration approaches to the often-debilitating problem.
To improve efficiency and contract compliance for hospitals and other health care providers, Prodigo Solutions LLC today announced an exclusive agreement with MedAssets to offer its customers Prodigo's electronic-procurement marketplace solutions.
Bluechiip Limited - which has developed a unique asset-tracking solution initially for cryogenic sample management in the healthcare and life science industry - today announced that a successful pilot trial of its tracking solution by ATCC, a US-based leader in biological materials management and processes, has led to the first sales order for Bluechiip's products from ATCC.
A state-of-the-art engineering approach toward improving the neutralizing activity of a cross-reactive nanobody, previously generated against the original SARS virus, showed it can be an attractive and viable option against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study is published in the journal Advanced Therapeutics.
Researchers at Albert Einstein College of Medicine of Yeshiva University have identified a key player in the spread of breast cancer. The findings, published today in the online edition of Nature, identify a critical molecule that helps cancer spread beyond the primary tumor.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184946428 | NPI | - | NPPES |
| 102498458 0001 | Medicaid | PA | |
| 2510096 | Other | PA | HIGHMARK BLUE SHIELD |
| 7651921 | Other | AETNA | |
| 3826089000 | Other | INDEPENDENCE BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD056299-L (Pennsylvania) | Primary |
| Provider Name | Mohammad K Khan |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1578590212 PECOS PAC ID: 3072571900 Enrollment ID: I20041227000009 |
News Archive
Cell biologist Benjamin J. Perrin of the School of Science at Indiana University-Purdue University Indianapolis is advancing knowledge of age-related hearing loss with the goal of informing possible therapeutic cell-regeneration approaches to the often-debilitating problem.
To improve efficiency and contract compliance for hospitals and other health care providers, Prodigo Solutions LLC today announced an exclusive agreement with MedAssets to offer its customers Prodigo's electronic-procurement marketplace solutions.
Bluechiip Limited - which has developed a unique asset-tracking solution initially for cryogenic sample management in the healthcare and life science industry - today announced that a successful pilot trial of its tracking solution by ATCC, a US-based leader in biological materials management and processes, has led to the first sales order for Bluechiip's products from ATCC.
A state-of-the-art engineering approach toward improving the neutralizing activity of a cross-reactive nanobody, previously generated against the original SARS virus, showed it can be an attractive and viable option against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study is published in the journal Advanced Therapeutics.
Researchers at Albert Einstein College of Medicine of Yeshiva University have identified a key player in the spread of breast cancer. The findings, published today in the online edition of Nature, identify a critical molecule that helps cancer spread beyond the primary tumor.
› Verified 1 days ago
News Archive
Cell biologist Benjamin J. Perrin of the School of Science at Indiana University-Purdue University Indianapolis is advancing knowledge of age-related hearing loss with the goal of informing possible therapeutic cell-regeneration approaches to the often-debilitating problem.
To improve efficiency and contract compliance for hospitals and other health care providers, Prodigo Solutions LLC today announced an exclusive agreement with MedAssets to offer its customers Prodigo's electronic-procurement marketplace solutions.
Bluechiip Limited - which has developed a unique asset-tracking solution initially for cryogenic sample management in the healthcare and life science industry - today announced that a successful pilot trial of its tracking solution by ATCC, a US-based leader in biological materials management and processes, has led to the first sales order for Bluechiip's products from ATCC.
A state-of-the-art engineering approach toward improving the neutralizing activity of a cross-reactive nanobody, previously generated against the original SARS virus, showed it can be an attractive and viable option against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study is published in the journal Advanced Therapeutics.
Researchers at Albert Einstein College of Medicine of Yeshiva University have identified a key player in the spread of breast cancer. The findings, published today in the online edition of Nature, identify a critical molecule that helps cancer spread beyond the primary tumor.
› Verified 1 days ago
Lvpg Neuropsychology - 1250 Cedar Crest Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1250 S Cedar Crest Blvd, Suite 410, Allentown, PA 18103 Phone: 610-402-3500 | |
Catholic Charities, Allentown Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 402 Chew St, Allentown, PA 18102 Phone: 610-435-1541 | |
Ida Andrea Olmeda Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1700 Hanover Ave, Allentown, PA 18109 Phone: 484-357-7599 Fax: 610-439-8004 | |
Bayada Home Health Care, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 961 Marcon Blvd Ste 103, Allentown, PA 18109 Phone: 484-795-5920 Fax: 484-795-5921 | |
Jewish Family Service Of The Lehigh Valley Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2004 W Allen St, Allentown, PA 18104 Phone: 610-821-8722 | |
Vitalistic Therapeutic Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1406 W Hamilton St, Allentown, PA 18102 Phone: 610-433-4383 | |
Alicia Coffman Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1011 Brookside Rd Ste 302, Allentown, PA 18106 Phone: 484-809-9366 |